Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression.

Pandey, Swaroop Kumar; Shteinfer-Kuzmine, Anna; Chalifa-Caspi, Vered; Shoshan-Barmatz, Varda

Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression.

Pandey, Swaroop Kumar; Shteinfer-Kuzmine, Anna; Chalifa-Caspi, Vered; Shoshan-Barmatz, Varda.

Afiliação

Pandey SK; The National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Shteinfer-Kuzmine A; The National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Chalifa-Caspi V; Ilse Katz Institute for Nanoscale Science & Technology, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Shoshan-Barmatz V; The National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Front Oncol ; 12: 992260, 2022.

Article em En | MEDLINE | ID: mdl-36185255

Palavras-chave

SMAC; cell proliferation; immunosuppression; inflammation; lung cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel